Riverview Capital Advisers’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Riverview Capital Advisers's JNJ Position: Q2 2026 in Review
Riverview Capital Advisers reduced its Johnson & Johnson (JNJ) stake by 11% in Q2 2026, selling an estimated $76.2K and leaving 2,623 shares worth $666K. The position accounts for 0.19% of the portfolio, ranked #53.
Riverview Capital Advisers first reported a position in JNJ in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.48M in Q4 2025. 4,688 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Riverview Capital Advisers held 2,623 shares of Johnson & Johnson worth $666K as of Q2 2026.
- Riverview Capital Advisers sold 327 Johnson & Johnson shares in Q2 2026, an estimated $76.2K.
- Johnson & Johnson made up 0.19% of Riverview Capital Advisers's portfolio in Q2 2026, its #53 holding.
- Riverview Capital Advisers first reported a position in Johnson & Johnson in Q4 2021 and has held it in 19 quarters since.
- Riverview Capital Advisers's Johnson & Johnson position peaked at $1.48M in Q4 2025.
- 4,688 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Riverview Capital Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.